제약 프로세스용 다이어프램 밸브 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

The global market for Diaphragm Valves for Pharmaceutical Process was estimated to be worth US$ 139 million in 2024 and is forecast to a readjusted size of US$ 212 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Diaphragm Valves for Pharmaceutical Process cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A Diaphragm valve is a flexible, pressure responsive element that transmits force to throttle, open or close a valve. Diaphragm valves separate the flow stream from the closure element using an elastomeric diaphragm, which is a flexible, durable material. The diaphragm in a valve serves as a seal to prevent the liquid encountering other operating parts of the valve, avoiding contamination, corrosion and wear.

GEMU is one of the most important global key players of the diaphragm valves for pharmaceutical process, holds about 20% of shares of global diaphragm valves for pharmaceutical process market, other key players include Crane Co. (Saunders), SAMSON (SED Flow Control Gmbh), Burkert Fluid Control Systems, etc. Europe is the largest market, occupied for about 30 percent, followed by the Asia Pacific. In terms of materials, stainless steel is the largest segment, with a share of over 60%, and in terms of application, the pharmaceutical water system segment holds a share of over 30 percent.

Analysis of market drivers of diaphragm valves for pharmaceutical processes:

1. Policy compliance and industry standard upgrades

Global drug regulation is becoming stricter

FDA/EU GMP requirements: Aseptic preparation production must meet zero leakage standards, which promotes the upgrade of diaphragm valve materials (such as PTFE, EPDM) and sealing technology.

Data integrity specifications: For example, the GAMP5 guideline requires valves to have electronic recording functions, which supports pharmaceutical companies to pass FDA 21 CFR Part 11 certification.

China's policy promotion

The "Drug Production Supervision and Management Measures" requires regular verification of sterile drug production equipment, driving the demand for diaphragm valve replacement.

Tightening environmental protection policies have forced companies to adopt corrosion-resistant, low-leakage diaphragm valves to reduce waste liquid treatment costs.

2. Technological innovation and product iteration

Breakthrough in material science

The temperature tolerance of high-purity PTFE diaphragms has been increased to 180°C, which is compatible with SIP/CIP processes and reduces equipment downtime.

Metal diaphragm valves (such as Hastelloy) are used in highly corrosive media to extend their service life to more than 10 years.

Intelligent integration

Integrated sensors enable real-time monitoring of flow and pressure. For example, the GEMU 69X series supports the IO-Link protocol to improve process control accuracy.

Automated cleaning module (CIP) and diaphragm valve integrated design reduce cross-contamination risk.

Miniaturization and modularization

Micro diaphragm valves (diameter ≤ 6mm) are suitable for emerging scenarios such as bioreactors and microfluidic chips to promote the production of cell therapy drugs.

Modular design supports rapid replacement of valve cores and shortens equipment maintenance time.

III. Global pharmaceutical industry expansion

Breaking up of biopharmaceutical production capacity

The global biopharmaceutical market size is expected to reach US$560 billion in 2028. The production of monoclonal antibodies and ADC drugs requires high-purity diaphragm valves to control culture media/buffers.

Chinese biopharmaceutical companies (such as BeiGene and Hengrui Medicine) are accelerating factory construction, driving the growth of local diaphragm valve demand.

The rise of the CDMO industry

The global TOP10 CDMO companies (such as Lonza and Catalent) have expanded their production capacity, driving the scale of standardized diaphragm valve procurement.

Modular factories (such as GE Healthcare's KUBio) use pre-installed diaphragm valve systems to shorten project delivery cycles.

Penetration in emerging markets

The growth of generic drug production in India and Southeast Asia has driven the demand for cost-effective diaphragm valves.

The growth of the diaphragm valve market for pharmaceutical processes is driven by policy compliance, technological innovation, industrial expansion and supply chain reconstruction. In the future, companies need to focus on high-end material research and development, intelligent integration and global layout, while grasping high-growth tracks such as biopharmaceuticals and CDMO to cope with cost pressures and technical barriers and consolidate their market position.

This report aims to provide a comprehensive presentation of the global market for Diaphragm Valves for Pharmaceutical Process, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diaphragm Valves for Pharmaceutical Process by region & country, by Type, and by Application.

The Diaphragm Valves for Pharmaceutical Process market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diaphragm Valves for Pharmaceutical Process.

Market Segmentation

By Company

• GEMU
• Crane Co.(Saunders)
• SAMSON (SED Flow Control Gmbh)
• Burkert Fluid Control Systems
• INOXPA SAU
• Aquasyn
• Alfa Laval
• ITT
• NDV
• Hylok
• Swagelok
• Parker Hannifin
• Watson-Marlow Fluid Technology Group (ASEPCO)
• Steel & O'Brien
• Shanghai REMY
• Rodaff Fluid Tech

Segment by Type

• Stainless Steel
• Plastic
• Others

Segment by Application

• Pharmaceutical Water System
• CIP and SIP System
• Filtration and Filling
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Diaphragm Valves for Pharmaceutical Process manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Diaphragm Valves for Pharmaceutical Process in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Diaphragm Valves for Pharmaceutical Process in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Diaphragm Valves for Pharmaceutical Process Product Introduction
• 1.2 Global Diaphragm Valves for Pharmaceutical Process Market Size Forecast
  • 1.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value (2020-2031)
  • 1.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume (2020-2031)
  • 1.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Price (2020-2031)
• 1.3 Diaphragm Valves for Pharmaceutical Process Market Trends & Drivers
  • 1.3.1 Diaphragm Valves for Pharmaceutical Process Industry Trends
  • 1.3.2 Diaphragm Valves for Pharmaceutical Process Market Drivers & Opportunity
  • 1.3.3 Diaphragm Valves for Pharmaceutical Process Market Challenges
  • 1.3.4 Diaphragm Valves for Pharmaceutical Process Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Diaphragm Valves for Pharmaceutical Process Players Revenue Ranking (2024)
• 2.2 Global Diaphragm Valves for Pharmaceutical Process Revenue by Company (2020-2025)
• 2.3 Global Diaphragm Valves for Pharmaceutical Process Players Sales Volume Ranking (2024)
• 2.4 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Company Players (2020-2025)
• 2.5 Global Diaphragm Valves for Pharmaceutical Process Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Diaphragm Valves for Pharmaceutical Process Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Diaphragm Valves for Pharmaceutical Process Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Diaphragm Valves for Pharmaceutical Process
• 2.9 Diaphragm Valves for Pharmaceutical Process Market Competitive Analysis
  • 2.9.1 Diaphragm Valves for Pharmaceutical Process Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Diaphragm Valves for Pharmaceutical Process Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diaphragm Valves for Pharmaceutical Process as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Stainless Steel
  • 3.1.2 Plastic
  • 3.1.3 Others
• 3.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type
  • 3.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Type (2020-2031)
  • 3.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Type (%) (2020-2031)
• 3.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type
  • 3.3.1 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Diaphragm Valves for Pharmaceutical Process Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Pharmaceutical Water System
  • 4.1.2 CIP and SIP System
  • 4.1.3 Filtration and Filling
  • 4.1.4 Others
• 4.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application
  • 4.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Application (2020-2031)
  • 4.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Value, by Application (%) (2020-2031)
• 4.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application
  • 4.3.1 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Diaphragm Valves for Pharmaceutical Process Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region
  • 5.1.1 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2020-2025)
  • 5.1.3 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (2026-2031)
  • 5.1.4 Global Diaphragm Valves for Pharmaceutical Process Sales Value by Region (%), (2020-2031)
• 5.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region
  • 5.2.1 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2020-2025)
  • 5.2.3 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (2026-2031)
  • 5.2.4 Global Diaphragm Valves for Pharmaceutical Process Sales Volume by Region (%), (2020-2031)
• 5.3 Global Diaphragm Valves for Pharmaceutical Process Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 5.4.2 North America Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 5.5.2 Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Diaphragm Valves for Pharmaceutical Process Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 5.7.2 South America Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Diaphragm Valves for Pharmaceutical Process Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Diaphragm Valves for Pharmaceutical Process Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.3.2 United States Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.4.2 Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.5.2 China Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.6.2 Japan Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.7.2 South Korea Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Diaphragm Valves for Pharmaceutical Process Sales Value, 2020-2031
  • 6.9.2 India Diaphragm Valves for Pharmaceutical Process Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Diaphragm Valves for Pharmaceutical Process Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 GEMU
  • 7.1.1 GEMU Company Information
  • 7.1.2 GEMU Introduction and Business Overview
  • 7.1.3 GEMU Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 GEMU Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.1.5 GEMU Recent Development
• 7.2 Crane Co.(Saunders)
  • 7.2.1 Crane Co.(Saunders) Company Information
  • 7.2.2 Crane Co.(Saunders) Introduction and Business Overview
  • 7.2.3 Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Crane Co.(Saunders) Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.2.5 Crane Co.(Saunders) Recent Development
• 7.3 SAMSON (SED Flow Control Gmbh)
  • 7.3.1 SAMSON (SED Flow Control Gmbh) Company Information
  • 7.3.2 SAMSON (SED Flow Control Gmbh) Introduction and Business Overview
  • 7.3.3 SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 SAMSON (SED Flow Control Gmbh) Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.3.5 SAMSON (SED Flow Control Gmbh) Recent Development
• 7.4 Burkert Fluid Control Systems
  • 7.4.1 Burkert Fluid Control Systems Company Information
  • 7.4.2 Burkert Fluid Control Systems Introduction and Business Overview
  • 7.4.3 Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Burkert Fluid Control Systems Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.4.5 Burkert Fluid Control Systems Recent Development
• 7.5 INOXPA SAU
  • 7.5.1 INOXPA SAU Company Information
  • 7.5.2 INOXPA SAU Introduction and Business Overview
  • 7.5.3 INOXPA SAU Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 INOXPA SAU Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.5.5 INOXPA SAU Recent Development
• 7.6 Aquasyn
  • 7.6.1 Aquasyn Company Information
  • 7.6.2 Aquasyn Introduction and Business Overview
  • 7.6.3 Aquasyn Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Aquasyn Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.6.5 Aquasyn Recent Development
• 7.7 Alfa Laval
  • 7.7.1 Alfa Laval Company Information
  • 7.7.2 Alfa Laval Introduction and Business Overview
  • 7.7.3 Alfa Laval Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Alfa Laval Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.7.5 Alfa Laval Recent Development
• 7.8 ITT
  • 7.8.1 ITT Company Information
  • 7.8.2 ITT Introduction and Business Overview
  • 7.8.3 ITT Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 ITT Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.8.5 ITT Recent Development
• 7.9 NDV
  • 7.9.1 NDV Company Information
  • 7.9.2 NDV Introduction and Business Overview
  • 7.9.3 NDV Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 NDV Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.9.5 NDV Recent Development
• 7.10 Hylok
  • 7.10.1 Hylok Company Information
  • 7.10.2 Hylok Introduction and Business Overview
  • 7.10.3 Hylok Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Hylok Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.10.5 Hylok Recent Development
• 7.11 Swagelok
  • 7.11.1 Swagelok Company Information
  • 7.11.2 Swagelok Introduction and Business Overview
  • 7.11.3 Swagelok Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Swagelok Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.11.5 Swagelok Recent Development
• 7.12 Parker Hannifin
  • 7.12.1 Parker Hannifin Company Information
  • 7.12.2 Parker Hannifin Introduction and Business Overview
  • 7.12.3 Parker Hannifin Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Parker Hannifin Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.12.5 Parker Hannifin Recent Development
• 7.13 Watson-Marlow Fluid Technology Group (ASEPCO)
  • 7.13.1 Watson-Marlow Fluid Technology Group (ASEPCO) Company Information
  • 7.13.2 Watson-Marlow Fluid Technology Group (ASEPCO) Introduction and Business Overview
  • 7.13.3 Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Watson-Marlow Fluid Technology Group (ASEPCO) Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.13.5 Watson-Marlow Fluid Technology Group (ASEPCO) Recent Development
• 7.14 Steel & O'Brien
  • 7.14.1 Steel & O'Brien Company Information
  • 7.14.2 Steel & O'Brien Introduction and Business Overview
  • 7.14.3 Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Steel & O'Brien Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.14.5 Steel & O'Brien Recent Development
• 7.15 Shanghai REMY
  • 7.15.1 Shanghai REMY Company Information
  • 7.15.2 Shanghai REMY Introduction and Business Overview
  • 7.15.3 Shanghai REMY Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Shanghai REMY Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.15.5 Shanghai REMY Recent Development
• 7.16 Rodaff Fluid Tech
  • 7.16.1 Rodaff Fluid Tech Company Information
  • 7.16.2 Rodaff Fluid Tech Introduction and Business Overview
  • 7.16.3 Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Rodaff Fluid Tech Diaphragm Valves for Pharmaceutical Process Product Offerings
  • 7.16.5 Rodaff Fluid Tech Recent Development

8 Industry Chain Analysis

• 8.1 Diaphragm Valves for Pharmaceutical Process Industrial Chain
• 8.2 Diaphragm Valves for Pharmaceutical Process Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Diaphragm Valves for Pharmaceutical Process Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Diaphragm Valves for Pharmaceutical Process Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer